Hepatitis B virus screening and reactivation and management of patients with nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis from an endemic area-Reference-Cited by-同舟云学术

Hepatitis B virus screening and reactivation and management of patients with nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis from an endemic area

Published:2017-05-10 Issue:18 Volume:123 Page:3540-3549
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Lv Jia-Wei¹,Chen Yu-Pei¹,Huang Xiao-Dan¹,Zhou Guan-Qun¹,Chen Lei¹,Li Wen-Fei¹,Tang Ling-Long¹,Mao Yan-Ping¹,Guo Ying²,Xu Rui-Hua³,Ma Jun¹,Sun Ying¹^ORCID

Affiliation:

1. Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangzhou People's Republic of China

2. Clinical Trials Center, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangzhou People's Republic of China

3. Department of Medical Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangzhou People's Republic of China

Funder

Sun Yat-Sen University Clinical Research 5010 Program

National Natural Science Foundation of China

Science and Technology Project of Guangzhou City

National High Technology Research and Development Program of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference29 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin.,2015

2. Nasopharyngeal carcinoma incidence and mortality in China in 2010;Wei;Chin J Cancer.,2014

3. What is the best treatment of locally advanced nasopharyngeal carcinoma? An individual patient data network meta-analysis;Ribassin-Majed;J Clin Oncol.

4. Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial;Zhang;Lancet.,2016

5. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial;Sun;Lancet Oncol.,2016

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B Virus Reactivation in Cancer Patients Receiving Chemotherapy—A Systematic Review and Meta-Analysis;Seminars in Oncology;2024-08

2. Polygenic risk-stratified screening for nasopharyngeal carcinoma in high-risk endemic areas of China: a cost-effectiveness study;Frontiers in Public Health;2024-05-02

3. The individualized delineation of clinical target volume for primary nasopharyngeal carcinoma based on invasion risk of substructures: A prospective, real-world study with a large population;Radiotherapy and Oncology;2024-05

4. Screening for viral hepatitis B infection in cancer patients before receiving chemotherapy – A systematic review and meta‐analysis;Asia-Pacific Journal of Clinical Oncology;2024-03-21

5. Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinoma;Cancer Cell;2024-03